Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

BACKGROUND: Many high-risk coronary heart disease (CHD) patients on statin monotherapy do not achieve guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals, and combination lipid-lowering therapy may be considered for these individuals. The effect of adding ezetimibe to simvastatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Foody, JoAnne M, Toth, Peter P, Tomassini, Joanne E, Sajjan, Shiva, Ramey, Dena R, Neff, David, Tershakovec, Andrew M, Hu, Henry, Tunceli, Kaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833706/
https://www.ncbi.nlm.nih.gov/pubmed/24265554
http://dx.doi.org/10.2147/VHRM.S49840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833706/
https://www.ncbi.nlm.nih.gov/pubmed/24265554
http://dx.doi.org/10.2147/VHRM.S49840

Ejemplares similares